Growth Metrics

Regeneron Pharmaceuticals (REGN) Buildings (2016 - 2017)

Historic Buildings for Regeneron Pharmaceuticals (REGN) over the last 6 years, with Q4 2017 value amounting to $1.4 billion.

  • Regeneron Pharmaceuticals' Buildings rose 1277.35% to $1.4 billion in Q4 2017 from the same period last year, while for Dec 2017 it was $1.4 billion, marking a year-over-year increase of 1277.35%. This contributed to the annual value of $1.4 billion for FY2017, which is 1277.35% up from last year.
  • As of Q4 2017, Regeneron Pharmaceuticals' Buildings stood at $1.4 billion, which was up 1277.35% from $1.3 billion recorded in Q4 2016.
  • Regeneron Pharmaceuticals' 5-year Buildings high stood at $1.4 billion for Q4 2017, and its period low was $343.4 million during Q4 2013.
  • Its 5-year average for Buildings is $844.5 million, with a median of $760.5 million in 2015.
  • Its Buildings has fluctuated over the past 5 years, first skyrocketed by 9061.48% in 2015, then soared by 1277.35% in 2017.
  • Over the past 5 years, Regeneron Pharmaceuticals' Buildings (Quarter) stood at $343.4 million in 2013, then grew by 16.2% to $399.0 million in 2014, then surged by 90.61% to $760.5 million in 2015, then surged by 68.08% to $1.3 billion in 2016, then grew by 12.77% to $1.4 billion in 2017.
  • Its Buildings was $1.4 billion in Q4 2017, compared to $1.3 billion in Q4 2016 and $760.5 million in Q4 2015.